Literature DB >> 6511922

Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.

C J Packard, A Munro, A R Lorimer, A M Gotto, J Shepherd.   

Abstract

The metabolic fate of very low density lipoprotein can be examined by following the transit of its apolipoprotein B moiety through the delipidation cascade, which leads to low density lipoprotein. In this study we have used cumulative flotation ultracentrifugation to follow the metabolism of various lipoprotein subclasses that participate in this process in normal, hypertriglyceridemic (Type IV), and dysbetalipoproteinemic (Type III) subjects. Large triglyceride-rich very low density lipoproteins of Svedberg units of flotation (Sf) 100-400 were converted virtually quantitatively in normal subjects to smaller Sf 12-100 remnant particles. Only a minor fraction appeared thereafter in low density lipoproteins (Sf 0-12), most being removed directly from the plasma. Type IV hyperlipoproteinemic individuals converted the larger Sf 100-400 very low density lipoproteins to intermediate particles at approximately 50% of the control rate but thereafter their metabolism was normal (fractional clearance of Sf 12-100 particles in controls, 1.29 +/- 0.23 pools/d; in Type IV hypertriglyceridemics, 1.38 +/- 0.23 pools/d; n = 4 in each case). Since the apolipoprotein B in large triglyceride-rich particles did not contribute significantly to the mass of the low density lipoprotein apoprotein pool, the latter must come largely from another source. This was examined by following the metabolic fate of small very low density lipoproteins of Sf 20-60 or of the total lipoprotein spectrum of d less than 1.006 kg/liter (approximate Sf 20-400). The small particles were rapidly and substantially converted to low density lipoproteins, suggesting that the major precursor of the latter was to be found in this density range. Whereas only 10% of apolipoprotein B in Sf 100-400 lipoproteins reached the low density lipoprotein flotation range, greater than 40% of Sf 20-100 B protein eventually appeared in Sf 0-12 particles; and when very low density lipoprotein of d less than 1.006 kg/liter is used as a tracer of apolipoprotein B metabolism it is primarily this population of small very low density lipoprotein particles in the Sf 12-100 flotation range that is labeled. A detailed examination was made of apolipoprotein B metabolism in three dysbetalipoproteinemic subjects. The plasma clearance curves of their Sf 100-400 lipoproteins were distinctly biphasic. The quickly decaying component converted rapidly into remnants of Sf 20-60 at a near normal rate (0.56 vs. 0.62 pools/d in normal subjects). Its subsequent processing, however, was retarded. The more slowly catabolized fraction, comprising 30% of the total apolipoprotein B radioactivity, had no counterpart in normal or Type IV hyperlipoproteinemic individuals. These data, taken together, suggest that the very low density lipoprotein consists of a complex mixture of particles with different origins and fates. Within the Sf 20-100 flotation range there are at least two subcomponents. One represents remnants of larger triglyceride-rich particles which are catabolized slowly and feeds little apolipoprotein B into low density lipoprotein. The other is apparently secreted directly into this flotation interval and transfers significant amounts of B protein rapidly into Sf 0-12 lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6511922      PMCID: PMC425410          DOI: 10.1172/JCI111644

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Comparison between the use of isopropanol and tetramethylurea for the solubilisation and quantitation of human serum very low density apolipoproteins.

Authors:  L Holmquist; K Carlson; L A Carlson
Journal:  Anal Biochem       Date:  1978-08-01       Impact factor: 3.365

2.  Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat.

Authors:  O D Mjos; O Faergeman; R L Hamilton; R J Havel
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

3.  Lipoprotein of the density 1.006-1.020 in the plasma of patients with type III hyperlipoproteinaemia in the postabsorptive state.

Authors:  J R Patsch
Journal:  Eur J Clin Invest       Date:  1975-02       Impact factor: 4.686

4.  The biochemical, clinical, and genetic features of type III hyperlipoproteinemia.

Authors:  J Morganroth; R I Levy; D S Fredrickson
Journal:  Ann Intern Med       Date:  1975-02       Impact factor: 25.391

5.  Metabolsim of apoB and apoC lipoproteins in man: kinetic studies in normal and hyperlipoproteininemic subjects.

Authors:  M Berman; M Hall; R I Levy; S Eisenberg; D W Bilheimer; R D Phair; R H Goebel
Journal:  J Lipid Res       Date:  1978-01       Impact factor: 5.922

6.  Catabolism of very low density lipoprotein B apoprotein in man.

Authors:  M F Reardon; N H Fidge; P J Nestel
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

7.  The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations.

Authors:  D W Bilheimer; S Eisenberg; R I Levy
Journal:  Biochim Biophys Acta       Date:  1972-02-21

8.  Apoprotein composition of very low density lipoproteins of human serum.

Authors:  J P Kane; T Sata; R L Hamilton; R J Havel
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

9.  Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects.

Authors:  G Sigurdsson; A Nicoll; B Lewis
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

10.  Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia.

Authors:  R M Krauss; R I Levy; D S Fredrickson
Journal:  J Clin Invest       Date:  1974-11       Impact factor: 14.808

View more
  41 in total

1.  The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients.

Authors:  R W James; D Pometta
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

2.  Modulation of lipid profile by fish oil and garlic combination.

Authors:  N C Morcos
Journal:  J Natl Med Assoc       Date:  1997-10       Impact factor: 1.798

3.  Characterization of metabolic interrelationships and in silico phenotyping of lipoprotein particles using self-organizing maps.

Authors:  Linda S Kumpula; Sanna M Mäkelä; Ville-Petteri Mäkinen; Anna Karjalainen; Johanna M Liinamaa; Kimmo Kaski; Markku J Savolainen; Minna L Hannuksela; Mika Ala-Korpela
Journal:  J Lipid Res       Date:  2009-09-05       Impact factor: 5.922

4.  Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding.

Authors:  J S Cohn; D A Wagner; S D Cohn; J S Millar; E J Schaefer
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

Review 5.  Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.

Authors:  J P Desager; Y Horsmans
Journal:  Clin Pharmacokinet       Date:  1996-11       Impact factor: 6.447

6.  Effect of low density lipoprotein receptor deficiency on the metabolism of apolipoprotein B-100 in blood plasma. Kinetic studies in normal and Watanabe heritable hyperlipidemic rabbits.

Authors:  N Yamada; D M Shames; R J Havel
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

7.  Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism.

Authors:  B W Walsh; F M Sacks
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size.

Authors:  Daniël B van Schalkwijk; Albert A de Graaf; Ben van Ommen; Kees van Bochove; Patrick C N Rensen; Louis M Havekes; Niek C A van de Pas; Huub C J Hoefsloot; Jan van der Greef; Andreas P Freidig
Journal:  J Lipid Res       Date:  2009-06-10       Impact factor: 5.922

9.  Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects.

Authors:  T Demant; D Bedford; C J Packard; J Shepherd
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

10.  Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in patients with familial dysbetalipoproteinemia.

Authors:  A F Stalenhoef; M J Malloy; J P Kane; R J Havel
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.